Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.22
-0.07 (-0.68%)
At close: Apr 28, 2026, 4:00 PM EDT
10.42
+0.20 (1.96%)
After-hours: Apr 28, 2026, 7:36 PM EDT
Arvinas Employees
Arvinas had 246 employees as of December 31, 2025. The number of employees decreased by 184 or -42.79% compared to the previous year.
Employees
246
Change (1Y)
-184
Growth (1Y)
-42.79%
Revenue / Employee
$1,067,480
Profits / Employee
-$328,455
Market Cap
653.68M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| CorMedix | 191 |
| Prime Medicine | 146 |
| Alpha Tau Medical | 121 |
| BridgeBio Oncology Therapeutics | 92 |
| Lexicon Pharmaceuticals | 81 |
| Aclaris Therapeutics | 73 |
| Prothena Corporation | 67 |
ARVN News
- 5 weeks ago - Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson's Disease Treated for 28 Days - GlobeNewsWire
- 6 weeks ago - Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders - GlobeNewsWire
- 7 weeks ago - Arvinas Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Arvinas Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Arvinas Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Arvinas Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire